
Florida Blue, Broward Health hit standstill over costs. What it means for patients
As of July 1, Broward Health is no longer an in-network provider for Florida Blue, ending a decades-long agreement with one of the largest insurers in the state. Florida Blue made the announcement this week, stating that Broward Health 'has chosen to leave the Florida Blue network' after rate negotiations between the two organizations fell through.
For Broward Health patients who have insurance through Florida Blue, that means they may need to find new doctors who are in the Florida Blue network to get cheaper — or covered — medical care. If not, they might find themselves paying a heftier bill for primary and specialty care at Broward Health, which is now an out-of-network provider for Florida Blue members.
'We are disappointed that Broward Health has chosen to leave our network of providers, and hope this is temporary,' Florida Blue said in a statement. 'Unfortunately, Broward Health's rate demands remain excessive and unsustainable, and would burden our community with much higher health care costs. We ask their senior leaders to return to the negotiating table and work with us in finding a reasonable solution that protects our members, preserves affordability, and works for everyone.'
In a blog post for patients, Broward Health said that Florida Blue has 'historically undervalued the care our team members provide' and that its discussions with the health insurer were about 'fairness.'
The public hospital system said it asked Florida Blue to reimburse its team at levels that are 'comparable' to what it reimburses other South Florida health care providers and the rates provided by other insurance companies for the same services.
Florida Blue said it notified about 18,000 members in May about the situation, including patients who had received care at Broward Health in the last six months or who have a Broward Health primary care doctor.
Broward Health, which mainly serves central and northern Broward County, is one of the 10 largest public health systems in the country, with five hospitals and more than 50 health centers and physician practices. It's one of two public hospital systems in Broward County, the other being Memorial Healthcare System, which mainly serves southern Broward.
Who is affected?
As of July 1, all Broward Health services, facilities, clinics and physicians will be impacted by the standstill between Broward Health and Florida Blue, which was previously known as Blue Cross Blue Shield.
Patients affected by the stalled negotiations include those with 'commercial (employer-based), individual marketplace and Medicare Advantage' plans, according to Broward Health. The hospital system said Medicare Supplemental and Medigap plans would not be impacted.
Florida Blue members can also still go to Broward Health for emergency care, as 'ER and emergency services are always covered at in-network cost share, even at out-of-network facilities,' according to Florida Blue.
The health insurer said some patients may still be able to continue getting in-network care at Broward Health for a certain period of time under federal and state protections for continuity of care. This includes people who are pregnant or who are 'undergoing active treatment for serious and complex health conditions, or in post-operative care following surgery,' according to Florida Blue.
Patients with questions can visit Florida Blue's website or call the number on the back of their member ID card for more info specific to their plan.
This article will be updated.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
UnitedHealth Group Incorporated (UNH) Expands Rural Care with $7M in Maternal Health Grants
We recently compiled a list of It is the largest U.S. health insurer, operating through its insurance arm (UnitedHealthcare) and health services division (Optum). It serves over 50 million people and continues to focus on transforming care delivery through value-based care, integrated services, and investments in social determinants of health. In May 2025, Stephen J. Hemsley returned as CEO, replacing Andrew Witty. The leadership shift comes amid uncertainty, with the company withdrawing its 2025 financial outlook but reaffirming its long-term goals of improving healthcare access, quality, and affordability. UNH is expanding care access, particularly for underserved and rural populations. Through the UnitedHealth Foundation, the company partnered with Cherokee Health Systems to improve rural prescription delivery. It also committed $7 million in grants to maternal and infant health, and its affordable housing-linked health investments reached $1.2 billion. A major project in Minneapolis will include 83 housing units and a new health center expected to serve 3,000 additional patients annually. For 2025, UnitedHealth Group Incorporated (NYSE:UNH) introduced 140 new Medicare Advantage plans, expanding support for chronically ill and dual-eligible populations. The Chronic Special Needs Plans (C-SNPs) will significantly increase coverage. Optum plans to serve 650,000 more patients under value-based care, leveraging AI tools to enhance coordination and preventive care. 15 States with the Best Healthcare in the US Optum is deepening its home-care services following its 2023 acquisition of LHC Group and now aims to acquire Amedisys. If approved, the deal would give Optum major market share in several states. However, the Department of Justice is reviewing the merger for potential antitrust violations. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Insider
a day ago
- Business Insider
J.P. Morgan Weighs In on UnitedHealth Stock Amid DOJ Scrutiny
UnitedHealth (NYSE:UNH) stock slipped again on Thursday, a familiar pattern in what's shaping up to be a rough year. Shares have tumbled 44% year-to-date, weighed down by a string of negative developments, including disappointing Q1 results, a CEO change, the suspension of guidance, and rising costs tied to UHC's Medicare Advantage members. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Thursday's 5% drop was driven by renewed scrutiny over an ongoing legal matter. UNH disclosed that it had proactively reached out to the DOJ following a February Wall Street Journal report revealing a civil investigation into its Medicare Advantage risk-coding practices. In its latest filing, the company confirmed that it is now responding to formal civil and criminal inquiries, has launched its own internal review, and remains cooperative with CMS audits. UNH also pointed to a favorable March ruling from a Special Master in a separate, long-running DOJ civil case as a sign of how past challenges have played out. This shift from 'unaware' in February to 'proactively cooperating' now isn't surprising to J.P. Morgan analyst Lisa Gill, who views the company's engagement as part of a broader defense of its practices. 'While we are not lawyers,' Gill noted, 'we note that if the court were to view this case similarly to previous ones brought forth by DOJ regarding the False Claims Act (FCA), we believe that this would place the burden of proof on the DOJ to prove improper coding.' Though the investigation has added another layer of uncertainty, Gill contextualizes it within broader industry trends. The analyst points to risk-adjustment programs like RADV and regulatory updates like V28 as ongoing efforts to refine coding practices across the Medicare Advantage landscape. Viewed through that lens, the current probes may ultimately reflect how companies have adapted, rather than acted improperly. Still, Gill acknowledges the ambiguity facing investors. The company's filing offers limited detail, and any legal proceedings stemming from the DOJ's inquiries are likely to be drawn out. Much could hinge on the outcome of the ongoing DOJ-backed civil case – one in which the Special Master recently recommended dismissal due to lack of evidence, though the DOJ has challenged that recommendation. In the meantime, Gill is looking ahead to next week's earnings call for added clarity, and remains optimistic. The analyst assigns UNH an Overweight (i.e., Buy) rating and $418 price target, suggesting the stock could rebound by 48% over the next 12 months. (To watch Gill's track record, click here) And she's not alone. 17 other analysts share Gill's bullish outlook, while 5 remain on the sidelines and just one is bearish. Altogether, the stock carries a Moderate Buy consensus rating. The average price target stands at $348.12, implying a ~24% upside from current levels. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
2 days ago
- Yahoo
Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty
Elevance Health, Inc. (NYSE:ELV) ranks among the . Wells Fargo kept its Overweight rating on Elevance Health, Inc. (NYSE:ELV) on July 15, but lowered its price target on the health insurer from $478 to $400. Wells Fargo applied a lower multiple of 10.5x to its 2026 earnings per share projection of $38.05, which is less than the previous multiple of 11.5x. designer491/ Wells Fargo stated that the primary driver of the reduced value multiple was uncertainty regarding margins in the Medicaid, Medicare Advantage (MA), and Health Insurance Exchange (HIX) segments for 2025. The firm also pointed out that there was 'relatively low visibility to improvement in 2026,' especially in the Medicaid and Health Insurance Exchange segments. However, it insisted that Elevance's valuation 'remains compelling once dust settles on estimates.' Elevance Health, Inc. (NYSE:ELV), previously Anthem, Inc., is a leading health-benefits provider in the United States. The company offers medical, pharmaceutical, dental, long-term care, disability, and behavioral health insurance under numerous brands, including Anthem Blue Cross, Blue Shield, Wellpoint, and Carelon. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data